• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者感染的管理:共识会议报告。

Management of infections in cirrhotic patients: report of a consensus conference.

机构信息

Gastroenterology and Transplant Hepatology, Papa Giovanni XXIII Hospital, Bergamo, Italy.

Medical Area Department, Lecco Hospital, Italy.

出版信息

Dig Liver Dis. 2014 Mar;46(3):204-12. doi: 10.1016/j.dld.2013.07.015. Epub 2013 Sep 8.

DOI:10.1016/j.dld.2013.07.015
PMID:24021271
Abstract

The statements produced by the consensus conference on infection in end-stage liver disease promoted by the Italian Association for the Study of the Liver, are here reported. The topics of epidemiology, risk factors, diagnosis, prophylaxis, and treatment of infections in patient with compensated and decompensated liver cirrhosis were reviewed by a scientific board of experts who proposed 26 statements that were graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. By systematic literature search of available evidence, comparison and discussion of expert opinions, pertinent statements answering specific questions were presented and approved. Short comments were added to explain the basis for grading evidence particularly on case of controversial areas.

摘要

本文报道了由意大利肝脏研究协会组织的感染性疾病共识会议的相关内容。会议对代偿期和失代偿期肝硬化患者的流行病学、危险因素、诊断、预防和治疗进行了讨论。专家组对这些内容进行了综述,提出了 26 条推荐意见,这些意见按照证据水平和推荐强度进行分级,并由独立评审团进行了审议。专家组通过对现有文献进行系统检索,对专家意见进行比较和讨论,提出并批准了能够回答具体问题的相关推荐意见。对于证据分级的依据,特别是存在争议的领域,都添加了简短的注释说明。

相似文献

1
Management of infections in cirrhotic patients: report of a consensus conference.肝硬化患者感染的管理:共识会议报告。
Dig Liver Dis. 2014 Mar;46(3):204-12. doi: 10.1016/j.dld.2013.07.015. Epub 2013 Sep 8.
2
Italian consensus conference for colonic diverticulosis and diverticular disease.意大利结肠憩室病和憩室疾病共识会议。
United European Gastroenterol J. 2014 Oct;2(5):413-42. doi: 10.1177/2050640614547068.
3
Comment on "Management of infections in cirrhotic patients: report of a consensus conference" S Fagiuoli et al. [Dig liver dis 2014;46:204-212].对“S Fagiuoli等人的《肝硬化患者感染的管理:共识会议报告》[《肝脏病学杂志》2014年;46卷:204 - 212页]的评论”
Dig Liver Dis. 2014 Jun;46(6):573-4. doi: 10.1016/j.dld.2014.01.155. Epub 2014 Mar 4.
4
[Antibiotics and antimycotics in oncology].[肿瘤学中的抗生素与抗真菌药]
Vnitr Lek. 1991 Jul-Aug;37(7-8):695-702.
5
[Chemotherapy of compromised hosts].[免疫功能低下宿主的化疗]
Nihon Saikingaku Zasshi. 1987 Nov;42(6):817-21.
6
[Management of microbial infections in myeloid leukemia].[髓系白血病中微生物感染的管理]
Nihon Rinsho. 2009 Oct;67(10):1969-73.
7
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.肝硬化患者的止血平衡:共识会议报告
Dig Liver Dis. 2016 May;48(5):455-467. doi: 10.1016/j.dld.2016.02.008. Epub 2016 Feb 27.
8
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials.新型策略用于管理肝硬化患者的细菌和真菌感染:聚焦新型抗菌药物。
Expert Rev Anti Infect Ther. 2020 Mar;18(3):191-202. doi: 10.1080/14787210.2020.1725473. Epub 2020 Feb 13.
9
Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.终末期肝病和肝移植中细菌和真菌感染的管理:现有选择和未来方向。
World J Gastroenterol. 2018 Oct 14;24(38):4311-4329. doi: 10.3748/wjg.v24.i38.4311.
10
[Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].[循证医学概念在发热性中性粒细胞减少症治疗证据中的应用]
Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:95-102.

引用本文的文献

1
Vaccination for solid organ transplanted patients: Recommendations, efficacy, and safety.实体器官移植患者的疫苗接种:建议、疗效与安全性
World J Transplant. 2024 Dec 18;14(4):92172. doi: 10.5500/wjt.v14.i4.92172.
2
The LIVERAID (LIVER And Infectious Diseases)-ICU score predicts in-hospital mortality in liver cirrhosis patients with infections in the intensive care unit.LIVERAID(肝脏和传染病)-ICU 评分可预测 ICU 中感染的肝硬化患者的院内死亡率。
BMJ Open Gastroenterol. 2024 Oct 8;11(1):e001482. doi: 10.1136/bmjgast-2024-001482.
3
Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review.
肝硬化患者头孢曲松、庆大霉素、美罗培南和万古霉素的药代动力学:系统评价。
J Antimicrob Chemother. 2024 Nov 4;79(11):2750-2761. doi: 10.1093/jac/dkae310.
4
Microbiological Characteristics and Antibiotic Sensitivity in Patients with Nosocomial Spontaneous Bacterial Peritonitis Caused by : A Multicenter Study.由……引起的医院获得性自发性细菌性腹膜炎患者的微生物学特征及抗生素敏感性:一项多中心研究
Infect Microbes Dis. 2020 Aug 7;2(4):167-172. doi: 10.1097/IM9.0000000000000035. eCollection 2020 Dec.
5
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients.实体器官移植成年候选者及受者的疫苗接种建议
Vaccines (Basel). 2023 Oct 18;11(10):1611. doi: 10.3390/vaccines11101611.
6
Management of sepsis in a cirrhotic patient admitted to the intensive care unit: A systematic literature review.入住重症监护病房的肝硬化患者脓毒症的管理:一项系统文献综述。
World J Hepatol. 2023 Jun 27;15(6):850-866. doi: 10.4254/wjh.v15.i6.850.
7
Challenges and recommendations when selecting empirical antibiotics in patients with cirrhosis.肝硬化患者经验性选择抗生素时的挑战与建议
World J Hepatol. 2023 Mar 27;15(3):377-385. doi: 10.4254/wjh.v15.i3.377.
8
Approaches for Selective Vaccinations in Cirrhotic Patients.肝硬化患者的选择性疫苗接种方法。
Vaccines (Basel). 2023 Feb 16;11(2):460. doi: 10.3390/vaccines11020460.
9
Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.肝硬化患者的细菌感染:别被细菌搞死。
Dig Dis Sci. 2020 Jan;65(1):31-37. doi: 10.1007/s10620-019-05943-6.
10
Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department.内科肝硬化患者的细菌感染
GE Port J Gastroenterol. 2019 Aug;26(5):324-332. doi: 10.1159/000494568. Epub 2018 Dec 17.